Loading clinical trials...
Loading clinical trials...
IMetelstat and Azacitidine With or Without Venetoclax GIveN in rElapsed Acute Myeloid Leukemia (IMAGINE Trial)
Conditions
Interventions
Imetelstat
Azacitidine
+1 more
Locations
1
United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Start Date
January 2, 2026
Primary Completion Date
June 17, 2030
Completion Date
June 15, 2035
Last Updated
April 22, 2026
NCT06177067
NCT06741722
NCT02996474
Lead Sponsor
Douglas Tremblay
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions